Atherosclerosis: Clinical Trials

30 trials for Atherosclerosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

15 completed, 6 unknown, 5 recruiting, 2 not yet recruiting. 30 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 130Completed 15, Unknown 6, Recruiting 5, Not yet recruiting 2, Enrolling by invitation 1, Terminated 1

Follow Atherosclerosis: new trials by email Literature Review of Atherosclerosis trials Research Report on Atherosclerosis

Trials (filtered) newest first · largest first

All 30 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Vitamin B6 on Exercise Pressor Reflex on Leg Ischemia-reperfusion
Vitamin B6 25 MG, Vitamin B6 50 MG, Vitamin B6 100 MG - Ischemia Reperfusion Injury, Peripheral Artery Disease
Early Phase 1Not yet recruitingMilton S. Hershey Medical Center302027-12-012026-03-17
Study to Image Inflammatory Activity of a Fluorescence Imaging Agent in Excised Human Artery Plaques
Pegulicianine, Placebo - Carotid Artery Diseases, Peripheral Arterial Disease
Early Phase 1Not yet recruitingMassachusetts General Hospital252027-06-012026-11-10
PET Imaging of Natriuretic Peptide Receptor C (NPR-C) in Carotid Atherosclerosis With 64Cu-NODAGA-CANF (Volunteer - Dosimetry Study)
64Cu-NODAGA-CANF - Healthy Adult, Healthy
Early Phase 1RecruitingWashington University School of Medicine82026-08-192026-09-02
Truway Diagnostic Tools in Primary Care
Truway Portable Ultrasound Device, Truway Blood Glucose Monitor, Standard Oral Hypoglycemic Agent - Chronic Disease, Type 2 Diabetes Mellitus (T2DM), Obesity, Overweight
Early Phase 1Enrolling by invitationTruway Health, Inc.2002025-10-012026-11-05
A Clinical Study of IMC-001 for Injection in Improving Atherosclerotic Plaque Stability in Patients With Acute Coronary Syndrome.
IMC-001 and Optimal medical treatment, IMC-001 placebo and optimal medical treatment - Atherosclerosis
Early Phase 1RecruitingImmuneOnco Biopharmaceuticals (Shanghai) Inc.182025-03-102026-04-15
Placebo-controlled Study of Single and Multiple Ascending Doses of UDP-003 in Healthy Human Participants and Followed by an Open-label Patient Cohort
UDP-003, Placebo - Atherosclerotic Cardiovascular Disease, Acute Coronary Syndromes
Early Phase 1RecruitingCyclarity Therapeutics, Inc.842025-02-252026-09-25
Impact of Nrf2 Activation on Macrovascular, Microvascular & Leg Function & Walking Capacity in Peripheral Artery Disease
Vumerity, Placebo - Peripheral Artery Disease, Peripheral Vascular Diseases
Early Phase 1RecruitingUniversity of Nebraska202024-11-142026-06-24
Mechanistic Clinical Trial of Colchicine in Patients With Peripheral Artery Disease
Colchicine, Placebo - Peripheral Artery Disease
Early Phase 1CompletedUniversity of Pennsylvania242024-09-252026-04-02
Safety, Tolerability, and Biodistribution of [89Zr]Zr-DFO-APAC in Subjects With PAOD/CLI and Healthy Volunteers (Acronyms: 89Zr = Zirconium-89, DFO = Desferrioxamine, APAC = AntiPlatelet AntiCoagulant, PET/CT = Positron Emission Tomography/Computed Tomography)
[89Zr]Zr-DFO-APAC, PET/CT scan - Peripheral Arterial Occlusive Disease, Critical Limb Ischemia
Early Phase 1UnknownAplagon Oy102024-02-012025-01-30
Umbilical Cord Artery-derived Perivascular Stem Cells for the Critical Limb Ischemia Therapy
UCA-PSCs/bFGF or bFGF Intramuscular injection - Critical Limb Ischemia
Early Phase 1UnknownNanjing University402023-06-302023-12-18
Outcomes of Rivaroxaban and Aspirin in PAD After Endovascular Revascularization
Rivaroxaban and Aspirin - Peripheral Arterial Disease
Early Phase 1UnknownAssiut University1002022-08-012022-07-20
68Ga-FAPI PET/MR for Atherosclerosis
68Ga-FAPI - Atherosclerosis
Early Phase 1UnknownPeking Union Medical College Hospital1002021-05-262021-09-08
A Genomic Approach for Clopidogrel in Caribbean Hispanics
CYP2C19 test, P2RY12 assay - Cardiovascular Disease (CVD), Stroke
Early Phase 1CompletedUniversity of Puerto Rico1502020-09-012026-06-02
Ertugliflozin: Cardioprotective Effects on Epicardial Fat
Ertugliflozin - Cardiovascular Diseases, Atherosclerosis
Early Phase 1CompletedStanford University612020-07-012026-06-04
Ultrasound Evaluation of Lower Extremity Arteries After Topical Nitroglycerin Administration
Nitroglycerin Topical Product - Peripheral Arterial Disease
Early Phase 1UnknownDeborah Heart and Lung Center802019-12-302019-11-08
Nutrition in Patient With Critical Limb Ischemia
Ensure Surgery Immunonutrition Shake, Ensure Enlive Advanced Nutrition Shake - Critical Limb Ischemia, Malnutrition
Early Phase 1RecruitingBoston Medical Center302018-10-022026-09-29
The Effect of Prednisone on Atherogenesis as Studied in the Macrophage Foam Cell Formation Model System.
Prednisone 20 Mg, Prednisone 40 Mg - Atherosclerosis, Dyslipidemias
Early Phase 1CompletedProf. Tony hayek MD102018-01-172019-02-21
PPG Project 3 - PET/MRI of the Brain-hematopoiesis-atherosclerosis Axis in PTSD Patients
fluorodeoxyglucose (FDG)-PET/MRI - PTSD, Trauma
Early Phase 1CompletedZahi Fayad1902017-11-282023-04-14
Angiotensin-(1-7) in Peripheral Arterial Disease
Angiotensin 1-7, Saline - Peripheral Arterial Disease
Early Phase 1TerminatedMilton S. Hershey Medical Center62017-09-012024-05-03
N-Acetyl-Cysteine (NAC) for Healing of Amputation Stumps in the Setting of Diabetes
Active Arm N-acetyl cysteine (NAC), Placebo Arm - Diabetes Mellitus, Critical Limb Ischemia
Early Phase 1CompletedWashington University School of Medicine332017-03-012024-08-16

Showing 20 of 30. Sign in to see all of them.

Narrower conditions

Peripheral Arterial Disease (15)  ·  Chronic Limb-Threatening Ischemia (5)  ·  Cardiovascular Diseases (4)  ·  Acute Coronary Syndrome (3)  ·  Diabetes Mellitus (3)  ·  Diabetes Mellitus, Type 2 (2)  ·  Inflammation (2)  ·  Peripheral Arterial Occlusive Disease 1 (2)  ·  Carotid Artery Diseases (1)  ·  Chronic Disease (1)  ·  Coronary Artery Disease (1)  ·  Dyslipidemias (1)  ·  Hyperlipidemias (1)  ·  Hypertension (1)

Broader conditions

Arterial Occlusive Diseases (30)  ·  Arteriosclerosis (30)  ·  Vascular Diseases (30)  ·  Cardiovascular Diseases (26)  ·  Peripheral Vascular Diseases (17)  ·  Pathologic Processes (10)  ·  Pathological Conditions, Signs and Symptoms (10)  ·  Disease Attributes (6)  ·  Ischemia (6)  ·  Chronic Disease (5)  ·  Nutritional and Metabolic Diseases (5)  ·  Endocrine System Diseases (4)  ·  Glucose Metabolism Disorders (4)  ·  Metabolic Diseases (4)

Interventions

Rosuvastatin Calcium (2)  ·  68Ga-FAPI (1)  ·  Acetates (1)  ·  Acetylcysteine (1)  ·  Aspirin (1)  ·  Chelation Therapy (1)  ·  Colchicine (1)  ·  Edetic Acid (1)  ·  Ezetimibe, Simvastatin Drug Combination (1)  ·  Fluorodeoxyglucose F18 (1)  ·  Hydroxymethylglutaryl-CoA-Reductases, NADP-dependent (1)  ·  IMC-001 (1)  ·  Losartan (1)  ·  Pioglitazone (1)  ·  Prednisone (1)

Sponsors

Washington University School of Medicine (3)  ·  AstraZeneca (2)  ·  Milton S. Hershey Medical Center (2)  ·  Peking Union Medical College Hospital (2)  ·  Aplagon Oy (1)  ·  Arkansas Heart Hospital (1)  ·  Assiut University (1)  ·  Augusta University (1)  ·  Boston Medical Center (1)  ·  Cyclarity Therapeutics, Inc. (1)  ·  Deborah Heart and Lung Center (1)  ·  ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (1)  ·  Kurume University (1)  ·  Massachusetts General Hospital (1)  ·  Medtronic Endovascular (1)

Countries

United States (13)  ·  China (4)  ·  Sweden (2)  ·  Australia (1)  ·  Canada (1)  ·  Israel (1)  ·  Japan (1)  ·  Netherlands (1)  ·  Puerto Rico (1)

Top investigators

Amy C Arnold, PhD (1)  ·  David Kandzari, MD (1)  ·  Gervasio Lamas, MD (1)  ·  Guillermo Tearney, MD, PhD (1)  ·  Gwenael Layec, PhD (1)  ·  Haiming Xia, phD (1)  ·  Jeffrey J Siracuse, MD (1)  ·  Jorge Duconge, PhD (1)  ·  Jun Pu, M.D. (1)  ·  Lu Qin (1)  ·  Maria Leonsson-Zachrissson, MD (1)  ·  Maria Leonsson-Zachrissson, MD, Study Physician (1)  ·  Meiqi Wu, M.D. (1)

Results publications

PMID 34415683, PMID 35129469, PMID 37761953, PMID 37873439, PMID 38106133, PMID 39242160

NIH funding

2023 (1), P01HL131478 (1), R01HL159803 (1), R01HL165453 (1), U54MD007600 (1)